News Search

In the nine months since the coronavirus emerged, the global medical community has learned about how to detect the virus, restrict its spread and better treat patients.

Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion.

Elkind serves as chief of the Division of Neurology Clinical Outcomes Research and Population Sciences in the Department of Neurology at CUIMC.

Researchers have converted a bacterial toxin into a genome editing tool that, for the first time, can make precise changes to DNA in mitochondria, the cell’s power plants.